Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2024 When Should Patients at the End of Life Get Antimicrobials? Noah Boton, MD and Jeffrey Larnard, MD Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes. AMA J Ethics. 2024;26(6):E456-462. doi: 10.1001/amajethics.2024.456. Case and Commentary Jun 2024 How Should Clinicians Navigate Interprofessional Tension in Their Roles as Antimicrobial Stewards? James B. Cutrell, MD and James M. Sanders, PhD, PharmD This commentary on a case describes need for clinician collaboration to optimize therapeutic use of antimicrobials in clinical settings. AMA J Ethics. 2024;26(6):E441-447. doi: 10.1001/amajethics.2024.441. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Case and Commentary Jun 2024 When Should Patients at the End of Life Get Antimicrobials? Noah Boton, MD and Jeffrey Larnard, MD Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes. AMA J Ethics. 2024;26(6):E456-462. doi: 10.1001/amajethics.2024.456.
Case and Commentary Jun 2024 How Should Clinicians Navigate Interprofessional Tension in Their Roles as Antimicrobial Stewards? James B. Cutrell, MD and James M. Sanders, PhD, PharmD This commentary on a case describes need for clinician collaboration to optimize therapeutic use of antimicrobials in clinical settings. AMA J Ethics. 2024;26(6):E441-447. doi: 10.1001/amajethics.2024.441.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.